Morningstar11d
Demand for CSL’s Plasma Products Persists as Supply Improves
It is likely that CSL has a faster turnaround time for repeat donors given its rewards program that incentivizes donors to earn redeemable points. This would aid the volume of plasma collected per ...
Business Insider3y
The $24 billion plasma industry may be putting donors at risk
According to analysts at Fortune Business Insights, two-thirds of these centers are owned by one of three companies: CSL Plasma, Grifols, and BioLife. Even before the pandemic hit, global demand ...
CSL Lifts 1H Net Profit by 3%, Led by Blood-Plasma Business -- Update
Pharmaceuticals company CSL on Tuesday reported a 3% rise in first-half profit, benefiting from further growth in its main blood-plasma business.
Morningstar11d
CSL Lifts 1st Half Net Profit by 3%, Led by Blood-Plasma Business — Update
Pharmaceuticals company CSL on Tuesday reported a 3% rise in first-half profit, benefiting from further growth in its main blood-plasma business. Australia-based CSL, which runs a network of ...